Prof. Dr. med. Dr. h.c.
Matthias H. Tschöp

Ludwig-Maxim­il­ians-Univer­sität München

Matthias Tschöp is the Presi­dent of Ludwig-Maxim­il­ians-Univer­sität München.

The medical scien­tist is one of the pioneers behind the ground­break­ing new medica­tions for the treat­ment of obesity. Follow­ing his discov­ery of the human hunger hormone ghrelin in 2000, he unrav­eled funda­men­tal gut–brain signals to develop medicines that safely normal­ize body weight in patients strug­gling with obesity. In close collab­o­ra­tion with his long-time chemist colleague Richard DiMarchi, he discov­ered the new class of dual and triple gut hormone medica­tions, the so-called poly-agonists (tirzepatide/retatrutide).

His honors include the Broer­mann Medical Innova­tion Award, which he received together with Svetlana Mojsov and Richard DiMarchi, the Rolf Luft Award, and the Banting Medal. He is an elected member of the Ameri­can Society for Clini­cal Inves­ti­ga­tion, the Associ­a­tion of Ameri­can Physi­cians, and the German National Academy of Sciences (Leopold­ina).

Medicine

Research Fields